D.A. Davidson & CO. Raises Stock Position in Colgate-Palmolive (NYSE:CL)

D.A. Davidson & CO. boosted its position in Colgate-Palmolive (NYSE:CL) by 0.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 106,176 shares of the company’s stock after purchasing an additional 135 shares during the quarter. D.A. Davidson & CO.’s holdings in Colgate-Palmolive were worth $11,022,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CL. Main Street Research LLC lifted its position in Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after purchasing an additional 100 shares during the last quarter. Advisor OS LLC grew its position in Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after acquiring an additional 101 shares in the last quarter. BLB&B Advisors LLC increased its stake in Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after acquiring an additional 104 shares during the last quarter. D Orazio & Associates Inc. lifted its stake in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after purchasing an additional 108 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. boosted its holdings in shares of Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock worth $349,000 after purchasing an additional 109 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on CL shares. UBS Group raised their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday. Piper Sandler began coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target for the company. Sanford C. Bernstein lifted their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a report on Tuesday, July 30th. Finally, Wells Fargo & Company dropped their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Price Performance

CL opened at $96.59 on Wednesday. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30. The company has a market cap of $78.91 billion, a price-to-earnings ratio of 27.68, a price-to-earnings-growth ratio of 3.39 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a fifty day simple moving average of $97.74 and a two-hundred day simple moving average of $98.59.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.